Trump Announces 100% Tariff on Imported Generic Drugs Set for 2028

US President Donald Trump declared on Tuesday that imported generic drugs will face a 100% tariff starting in August 2028. The move is intended to encourage pharmaceutical companies to manufacture these drugs within the United States. Generic drugs are cheaper alternatives to brand-name medications and are widely used by hospitals and patients. Currently, many generic drugs are produced overseas, particularly in countries like India. The tariff is part of a broader push to reduce US dependence on foreign supply chains for essential medicines. Trump argued that domestic production would enhance national security and ensure a stable supply of medications. Critics, however, warn that such a high tariff could lead to increased drug prices for American consumers and disrupt the generic drug market. The policy is set to take effect over three years from now, giving companies time to adjust their production strategies. The announcement has sparked debate among policymakers and industry experts about its potential impact on healthcare costs and drug availability. No further details on exceptions or implementation have been provided yet.